Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Harbin Pharmaceutical Group Holding Company

Harbin Pharmaceutical Group Holding Company
1989 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
600829 STOCK SYMBOL
3 INVESTMENTS
$1.18 SHARE PRICE (As of Friday Closing)
Description

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Website
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Distributors/Wholesale
Stock Exchange
SHG
Primary Office
  • Number 109 Xue Fu Road
  • Harbin City, Nangang District 150086
  • China

+86 0451 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Harbin Pharmaceutical Group Holding Company’s full profile, request a free trial.

Harbin Pharmaceutical Group Holding Company Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.70 - $1.50 $682M $1.15 $0.07 5.82M 580M

Harbin Pharmaceutical Group Holding Company Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 598,418 482,248 1,069,813 1,245,202
Revenue 1,104,387 1,066,504 1,185,105 1,352,018
EBITDA 57,582 59,618 57,293 50,592
Net Income 38,723 38,979 37,614 33,706
Total Assets 676,721 641,424 741,557 692,716
Total Debt 57,209 32,563 34,310 15,841
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Harbin Pharmaceutical Group Holding Company Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Harbin Pharmaceutical Group Holding Company‘s full profile, request access.

Request full access to PitchBook

Harbin Pharmaceutical Group Holding Company Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000 000 13-Feb-2018 00000 0000000 Distributors/Wholesale
0000000 000000000 13-Feb-2018 0000 00000 Specialty Retail 00000 00000
Pfizer(swine vaccine business) 31-May-2010 Merger/Acquisition 0000 Drug Delivery
To view this company’s complete investment and acquisition history, request access »

Harbin Pharmaceutical Group Holding Company Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Harbin Pharmaceutical Group Holding Company‘s full profile, request access.

Request full access to PitchBook

Harbin Pharmaceutical Group Holding Company Executive Team (2)

Name Title Board
Seat
Contact
Info
Lijun Zhang Chairman & General Manager
Chang Sun Director

Harbin Pharmaceutical Group Holding Company Board Members (1)

Name Representing Role Since Contact
Info
00000 00000 Harbin Pharmaceutical Group Holding Company Chairman & General Manager 000 0000